BridgeBio Oncology Therapeutics's total assets for Q4 2025 were $448.38M, a decrease of -7.51% from the previous quarter. BBOT total liabilities were $37.28M for the fiscal quarter, a -2.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.